Development of a Triple-Negative Breast Cancer Model Using Patient-Derived Tumor Fragments and Study of its Response to Exposure to Chemotherapeutic Agents. Voprosy onkologii, v. 71, n. 3, p. OF-2266, 30 Jun.2025.